Like the flu, S. pneumoniae can be passed on from person to person through talking, coughing and sneezing.
Prevnar 13 is not indicated to reduce complications of pneumococcal diseases, such as hospitalization and death.
Prevnar 13 should not be used if you are allergic (hypersensitive) to the active substances, to any other ingredients in the vaccine, or to any other vaccine that contains diphtheria toxoid.
Take special care with Prevnar 13:
• If you have any present or past medical problems after any dose of Prevnar or Prevnar 13
• If you are sick with a high fever
• If you have any bleeding problems
As with any vaccine, Prevnar 13 will not protect 100% of those who receive it.
Prevnar 13 is a conjugate polysaccharide* vaccine administered as a single dose into the arm or leg muscle. It is used for the prevention of diseases such as pneumonia, bacteraemic pneumonia, sepsis and meningitis caused by 13 types of the bacteria S. pneumoniae.
Polysaccharides are sugars that cover bacteria such as S. pneumoniae. Prevnar 13 contains 13 polysaccharides, each protecting you from one type of S. pneumoniae.
Conjugate: A process that links a protein to polysaccharides to enhance immune response to specific bacteria.
† The clinical significance of this comparison has not been evaluated.
Pneumococcal pneumonia and other pneumococcal diseases are serious but potentially preventable conditions.
Prevnar 13 is not indicated to reduce complications of pneumococcal diseases, such as hospitalization.
The most common side effects reported in at least 1 in 10 adults are decreased appetite, headache, diarrhea, rash, new/aggravated joint pain, new/aggravated muscle pain, chills, fatigue, any pain/tenderness/redness/swelling/hardness at the injection site, limitation of arm movement. Common side effects reported in at least 1 in 100 adults, but less than 1 in 10 adults, are vomiting (in adults aged 50 years and over) and fever.